Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxymatrine Plus Lamivudine vs Lamivudine in Chronic Hepatitis B
NCT02202473Phase 4Completed
- Sponsor
- Southeast University
- Primary completion
- Feb 2014
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Oxymatrine in Chronic Hepatitis B (CHB), sponsored by Southeast University. Status: completed.
02
Drugs
Oxymatrine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02202473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02202473.